Emergent Biosolutions Inc. Change in Cash

Change in Cash of EBS for past 10 years: annual, quarterly and twelve month trailing (TTM) including Change in Cash growth rates and interactive chart.


Highlights and Quick Summary

  • Change in Cash for the quarter ending June 30, 2023 was $-342 Million (a 60.83% increase compared to previous quarter)
  • Year-over-year quarterly Change in Cash increased by 191.22%
  • Annual Change in Cash for 2022 was $66.3 Million (a -246.68% decrease from previous year)
  • Annual Change in Cash for 2021 was $-45.2 Million (a -109.97% decrease from previous year)
  • Annual Change in Cash for 2020 was $454 Million (a 715.65% increase from previous year)
  • Twelve month Change in Cash ending June 30, 2023 was $-270 Million (a 4550.0% increase compared to previous quarter)
  • Twelve month trailing Change in Cash increased by 65.46% year-over-year
Trailing Change in Cash for the last four month:
30 Jun '23 31 Mar '23 31 Dec '22 30 Sep '22
$-270 Million $-5.8 Million $66.3 Million $-163 Million
Visit stockrow.com/EBS for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Change in Cash of Emergent Biosolutions Inc.

Most recent Change in Cashof EBS including historical data for past 10 years.

Interactive Chart of Change in Cash of Emergent Biosolutions Inc.

Emergent Biosolutions Inc. Change in Cash for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2023 $-341.6 $-212.4
2022 $401.6 $-117.3 $-77.7 $-140.3 $66.3
2021 $172.3 $-43.7 $-100.3 $-73.5 $-45.2
2020 $206.3 $146.2 $87.3 $13.7 $453.5
2019 $28.6 $-38.2 $40.2 $25.0 $55.6
2018 $-228.0 $149.1 $26.7 $-14.7 $-66.9
2017 $-162.68 $25.36 $45.46 $-1.34 $-93.2
2016 $-27.44 $-34.46 $-7.62 $28.22 $-41.3
2015 $4.08 $93.88 $-1.67 $-63.98 $32.3
2014 $38.25 $74.12 $7.92 $-19.12 $101.16
2013 $6.78 $16.32 $26.01 $-11.43 $37.67
2012 $-56.24 $36.06 $-2.24

Business Profile of Emergent Biosolutions Inc.

Sector: Healthcare
Industry: Drug Manufacturers Specialty & Generic